Related Insights

SVB's 2022 healthtech report reveals strong investment opportunity in mental health

 
Christopher Moniz

Healthcare Trends investments 1H2022 – Insight from experts

 
Jonathan Norris

Life science startup hubs: Advantages of Texas

 
Ben Johnson

First quarter healthcare industry trends worth tracking

 
Jonathan Norris

Healthcare industry sectors: An overview of 2021

 
Jonathan Norris

The Advantage of Oz: Offshore Tax Rebates for LSHC R&D in Australia

 
Anton Xavier and Mike Watson

About the Author

Julie Betts Ebert is a Managing Director on the National Life Science & Healthcare team at Silicon Valley Bank, covering the Mid-Atlantic and Southeast markets.  Julie provides specialized banking services and debt-financing solutions, as well as advice on strategic growth, to life science companies across all sectors and life stages, from early-stage venture-backed enterprises to late-stage public companies. 

Before joining the commercial banking team, Julie spent several years leading SVB’s Strategic Advisory effort, where she was responsible for managing client engagements and leading execution for advisory projects.

Prior to joining SVB, Julie worked for 10 years at Greenhill & Co LLC, a boutique investment bank, spending time in both their New York and London offices. While at Greenhill, Julie advised both public and private companies on M&A and restructuring transactions. She managed both buy-side and sell-side processes, completed complex corporate valuations, conducted transaction negotiations and provided strategic advice. Julie has broad experience across a range of sectors, with a focus on healthcare.

Before Greenhill, Julie also worked at Prudential Securities in the M&A Group and at J.P. Morgan in the Syndicated Leveraged Finance Group.

Julie received an M.B.A. with honors from Columbia Business School and a B.S. from the McIntire School of Commerce at the University of Virginia with concentration in finance.